Anakinra is used in the treatment ofA. Gout
B. RA
C. giant cell arteritis
D. Kawasaki disease
B. RA
C. giant cell arteritis
D. Kawasaki disease
Ans.
B. RA
Anakinra is a recombinant IL-1 receptor
antagonist. Anakinra has been shown to improve the signs and symptoms of RA, to
decrease disability, and to slow progression of articular damage assessed
radiographically. It can be given as monotherapy or in combination with
methotrexate.